Phase I Dose-Escalation Study of the Safety,...

Clinical Cancer Research 2012 / 09 Vol. 18; Iss. 17

Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the MEK Inhibitor RO4987655 (CH4987655) in Patients with Advanced Solid Tumors

Leijen, S., Middleton, M. R., Tresca, P., Kraeber-Bodere, F., Dieras, V., Scheulen, M. E., Gupta, A., Lopez-Valverde, V., Xu, Z.-X., Rueger, R., Tessier, J. J. L., Shochat, E., Blotner, S., Naegelen,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-12-0868
Date:
September, 2012
File:
PDF, 1.15 MB
english, 2012
Conversion to is in progress
Conversion to is failed